Correction: Combined MEK and ERK inhibition overcomes therapy-mediated pathway reactivation in RAS mutant tumors.

Autor: Merchant M, Moffat J, Schaefer G, Chan J, Wang X, Orr C, Cheng J, Hunsaker T, Shao L, Wang SJ, Wagle MC, Lin E, Haverty PM, Shahidi-Latham S, Ngu H, Solon M, Eastham-Anderson J, Koeppen H, Huang SA, Schwarz J, Belvin M, Kirouac D, Junttila MR
Jazyk: angličtina
Zdroj: PloS one [PLoS One] 2018 Jan 25; Vol. 13 (1), pp. e0192059. Date of Electronic Publication: 2018 Jan 25 (Print Publication: 2018).
DOI: 10.1371/journal.pone.0192059
Abstrakt: [This corrects the article DOI: 10.1371/journal.pone.0185862.].
Databáze: MEDLINE
Nepřihlášeným uživatelům se plný text nezobrazuje